Stability of Essential Drugs in Tropical Climates: Zimbabwe - EDM Research Series No. 013
(1994; 86 pages) Ver el documento en el formato PDF
Índice de contenido
Ver el documentoAbbreviations
Ver el documento1. Summary
Abrir esta carpeta y ver su contenido2. Introduction
Abrir esta carpeta y ver su contenido3. Study design and methods
Ver el documento4. Results
Abrir esta carpeta y ver su contenido5. Discussion
Abrir esta carpeta y ver su contenido6. Conclusions and recommendations
Ver el documentoReferences
Cerrar esta carpetaAnnexes
Cerrar esta carpetaAnnex 1: Detailed results for each drug
Ver el documento1.1 Amoxycillin capsules
Ver el documento1.2 Ampicillin capsules
Ver el documento1.3 Acetylsalicylic acid tablets
Ver el documento1.4 Doxycycline capsules
Ver el documento1.5 Ferrous sulfate tablets
Ver el documento1.6 Phenoxymethylpenicillin tablets
Ver el documento1.7 Tetracycline capsules
Ver el documento1.8 Retinol tablets
Ver el documento1.9 Epinephrine injection
Ver el documento1.10 Ampicillin injection
Ver el documento1.11 Benzylpenicillin injection
Ver el documento1.12 Ergometrine injection
Ver el documento1.13 Procaine penicillin injection
Ver el documentoAnnex 2: Validation of laboratory results
 

1.9 Epinephrine injection

SHELF LIFE

Manufacturers A, C:

2 years

 

Manufacturer D:

3 years

 

Manufacturer B:

4 years

ASSAY METHOD

HPLC method, USP 1990

 

Measured three times and mean taken.

ASSAY LIMITS

90 - 115% (USP)

 

SAMPLES OBTAINED

All Manuf.

Expired (all)

GMS samples

no.

%

no

%

Total

1

     

Harare

1

     

Bulawayo

0

     

Facility samples

       

Total

10

100

14

100

Age > 50% SLife

1

10

14

100

Facility type = PCH

4

40

12

86

Climate = hot

7

70

8

57

Transport = slow

5

50

8

57

Longitudinal series

       

Total

4

     

SUMMARY ASSAY RESULTS

 

All Manuf.

       

GMS samples

no.

%

       

Mean age (mths)

 

1.7

       

Mean assay

 

101.5%

       

95% CL

 

n/a

       

No, and % fail

0

0%

       

No. and % low fail

0

0%

       

No. and % high fail

0

0%

       

Facility samples

All Manuf.

Expired (all)

   

Mean age (mths)

 

5.1

 

29.5

   

Mean assay

 

102.5%

 

102.3%

   

95% CL

96.6- 108.3%

95.6- 109.0%

   

No, and % fail

2

20%

4

29%

   

No. and % low fail

1

10%

2

14%

   

No. and % high fail

1

10%

2

14%

   

Longitudinal series

at Manuf.

at GMS

at facility

Mean age (mths)

 

0.0

 

1.7

 

3.8

Mean assay

 

96.0%

 

101.5%

 

102.6%

95% CL

 

n/a

 

n/a

99.5 - 105.7%

No. and % fail

0

0%

0

0%

0

0%

 

Mean interval (mths)

2.1

 

Mean loss (-) or gain (+)

+1.1%

 

95% CL for loss/gain

-2.0 to +4.2%


Figure 1 - Results of facility samples

Findings:

a) 14 of 24 facility samples (58%) were expired; these results were analyzed separately.

b) Due to a stockout at GMS during the study period, only one GMS sample and four longitudinal series samples were obtained. The GMS sample was within assay specifications.

c) Two of 10 facility samples (20%) failed: one was below the lower limit (87.0%) and one was above the upper limit (123.6%).

d) Four of 14 expired samples (29%) failed; two were below the lower limit (85.4, 85.8%) and two were above the upper limit (117.0, 134.6%).

e) The mean assay for 14 expired samples was not lower than the mean for 10 "in date" samples despite a difference in a mean age of 24 months.

f) A wide range of assay values was seen (85.4 - 134.6%).

g) No loss of potency was found in four GMS/facility sample pairs, but the sample interval was short (mean 2.1 months).

h) There is no evidence of instability.

Ir a la sección anterior Ir a la siguiente sección
 

Última actualización: le 3 mayo 2013